Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALOX5 | P09917 | 1/20 | 0.49 |
| ▸ | PRKDC | P78527 | 6/20 | 0.38 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.35 |
| ▸ | ATM | Q13315 | 1/20 | 0.35 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.35 |
| ▸ | CA12 | O43570 | 3/20 | 0.34 |
| ▸ | CA1 | P00915 | 3/20 | 0.34 |
| ▸ | CA2 | P00918 | 3/20 | 0.34 |
| ▸ | CA9 | Q16790 | 3/20 | 0.34 |
| ▸ | PARP14 | Q460N5 | 1/20 | 0.34 |
| ▸ | MCL1 | Q07820 | 1/20 | 0.33 |
| ▸ | ACMSD | Q8TDX5 | 1/20 | 0.33 |
| ▸ | F9 | P00740 | 1/20 | 0.33 |
| ▸ | PIK3CD | O00329 | 2/20 | 0.32 |
| ▸ | PIK3CB | P42338 | 2/20 | 0.32 |
| ▸ | BRD4 | O60885 | 1/20 | 0.32 |
| ▸ | PIK3CA | P42336 | 1/20 | 0.32 |
| ▸ | MTOR | P42345 | 1/20 | 0.32 |
| ▸ | PIK3CG | P48736 | 1/20 | 0.32 |
| ▸ | KCNH2 | Q12809 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL780770 | 0.96 | ALOX5 (0.46) | ALOX5PRKDCKDM4EATML3MBTL1 | |
| SCHEMBL780664 | 0.93 | ALOX5 (0.47) | ALOX5PRKDCCA12CA1CA2 | |
| SCHEMBL18505069 | 0.93 | ALOX5 (0.46) | ALOX5PRKDCKDM4EATML3MBTL1 | |
| SCHEMBL10165726 | 0.93 | ALOX5 (0.49) | ALOX5PRKDCKDM4EATML3MBTL1 | |
| SCHEMBL10165709 | 0.93 | ALOX5 (0.51) | ALOX5PRKDCKDM4EATML3MBTL1 | |
| SCHEMBL13829525 | 0.93 | ALOX5 (0.56) | ALOX5PRKDCKDM4EATML3MBTL1 | |
| SCHEMBL23737855 | 0.92 | ALOX5 (0.41) | ALOX5PRKDCKDM4EATML3MBTL1 | |
| SCHEMBL10165702 | 0.92 | ALOX5 (0.48) | ALOX5PRKDCKDM4EATML3MBTL1 | |
| SCHEMBL16804106 | 0.92 | ALOX5 (0.50) | ALOX5PRKDCKDM4EATML3MBTL1 | |
| SCHEMBL13829706 | 0.92 | ALOX5 (0.54) | ALOX5PRKDCKDM4EATML3MBTL1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9133173-B2 | Carbazole compound, material for light-emitting element, organic semiconductor material, light-emitting element | SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) | 2015-09-15 | — | — | US | disclosed |
| US-9133173-B2 | Carbazole compound, material for light-emitting element, organic semiconductor material, light-emitting element | SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) | 2015-09-15 | — | — | US | disclosed |
| US-20120091887-A1 | Carbazole Compound, Material for Light-Emitting Element, Organic Semiconductor Material, Light-Emitting Element | SEMICONDUCTOR ENERGY LABORATORY CO., LTD. | 2012-04-19 | — | — | US | disclosed |
| US-20120091887-A1 | Carbazole Compound, Material for Light-Emitting Element, Organic Semiconductor Material, Light-Emitting Element | SEMICONDUCTOR ENERGY LABORATORY CO., LTD. | 2012-04-19 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120091887-A1 | Carbazole Compound, Material for Light-Emitting Element, Organic Semiconductor Material, Light-Emitting Element | NUTF2, BRI3BP, CLINT1 | ALOX5 1931/4885PRKDC 2968/4885KDM4E 2172/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.